MTIP AG

Dossier is a global leader in cloud-based competency management solutions for healthcare systems. It serves over 500,000 healthcare professionals worldwide, driving measurable results through its suite of services, which includes competence modeling, embedded checklists, competence plan creation and assignment, and an employee competence portal. Dossier's platform enables clients to access learning-focused portals, generate detailed reports, and analyze data in real-time, all centered around the principle of competence-driven people management.

Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

Hexarad is a technology-driven teleradiology company that specializes in the remote reporting of medical scans, including CTs, MRIs, and X-rays. The company's healthcare technology platform is designed to deliver diagnostic services efficiently while prioritizing patient-centric care. It integrates image analysis algorithms to interpret medical images and optimizes workflows for scheduling, assignment, prioritization, and tracking case progress. Additionally, Hexarad offers telemedicine features that facilitate remote consultations, enabling radiologists to reduce turnaround times for diagnostic reports. This leads to faster treatment decisions and improved patient outcomes.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

Apricity is the world's first virtual fertility clinic, designed to enhance the fertility treatment experience for women and couples facing challenges in conception. By integrating data and artificial intelligence, Apricity seeks to improve the chances of pregnancy success while providing a patient-centric approach. The company combines advanced technology with personalized care, offering at-home services and virtual appointments to streamline the treatment process. Led by a team of experienced entrepreneurs, medical professionals, and data scientists, Apricity aims to disrupt traditional fertility care by making it more accessible and efficient for patients.

LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.

Mediktor is a developer of an advanced pre-diagnosis tool that utilizes artificial intelligence and natural language recognition to facilitate accurate symptom checking, triage, and decision-making support. The system is clinically validated and aims to transform healthcare by reducing access barriers for patients. It allows individuals to make informed decisions based on their initial symptoms while enabling healthcare providers to efficiently manage demand and optimize resources. Mediktor's technology connects patients with medical professionals within health insurance networks, assisting hospitals and health systems in making safe, rapid, and cost-effective healthcare decisions.

Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

Intelligencia AI is an enterprise SaaS company that specializes in applying machine learning technology to enhance clinical development strategies. The company has developed a cloud-based platform that utilizes predictive analytics to assess, quantify, and mitigate risks associated with clinical trials. By estimating the probability of success for various trial designs, Intelligencia's platform allows healthcare organizations to optimize their approaches before initiating trials. This proactive risk management not only helps to save time and resources for clinical trials but also facilitates quicker access to innovative therapies for patients.

Koa Health B.V., founded in 2018 and headquartered in Amsterdam, specializes in digital healthcare solutions aimed at enhancing mental well-being in the workplace. The company, which also has offices in Barcelona, the United States, and the United Kingdom, develops a range of applications, including the koa foundation, to support employees' mental health. Koa Health's offerings incorporate the latest clinical research and technology to provide accessible and personalized mental health support across various conditions. Its product suite includes Foundations for managing mild mental health issues, Perspectives for delivering standalone cognitive-behavioral therapy (CBT) for more serious cases, and Mindset, which offers supervised digital-first CBT for patients at elevated clinical risk. Additionally, Koa Health provides a library of evidence-based activities designed to address stress, sleep improvement, relaxation, positive thinking, and self-confidence, making it a comprehensive resource for mental health prevention, prediction, and treatment.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Trialbee AB is an independent software company based in Malmö, Sweden, established in 2010. It specializes in developing a software-as-a-service solution aimed at enhancing patient matching and engagement in clinical trials. The company's platform facilitates patient recruitment, enrollment, and retention by providing various services such as resource libraries, adherence reminders, and comprehensive patient journey management. Trialbee's technology enables candidates to search for clinical trials and offers pre-screening and analysis tools, thus simplifying the clinical research process. The company serves a range of clients, including pharmaceutical sponsors, contract research organizations (CROs), investigator sites, and patients, with the goal of accelerating drug development through improved recruitment accuracy and efficiency.

Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.

ReActive Robotics GmbH, established in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's rehabilitation robots are specifically utilized for gait rehabilitation in neurological patients as well as in orthopedic patients recovering from joint replacements. With a team boasting over 12 years of combined experience in rehabilitation robotics and a strong network within the clinical community, ReActive Robotics is well-equipped to advance its innovative solutions in medical technology. The company emphasizes the importance of collaboration with advisors who support various aspects of product development, including patient access, engineering, legal compliance, and medical device registration.

Blueprint Genetics Oy is a clinical genetics testing company based in Helsinki, Finland, founded in 2012. It specializes in genetic diagnostics for rare diseases using advanced Next-Generation Sequencing (NGS) technologies. The company's services cater to hospitals and research groups, offering targeted genetic tests for a wide range of hereditary conditions, including cardiovascular diseases, cancer, and various inherited disorders. Blueprint Genetics aims to enhance the accessibility and quality of genetic diagnostics by utilizing innovative sequencing methods, such as its proprietary OS-Seq technology developed at Stanford University. The firm also provides customized sequencing and bioinformatics solutions, along with tailored services for researchers and diagnostics providers. As of early 2020, Blueprint Genetics operates as a subsidiary of Quest Diagnostics Incorporated.

ReActive Robotics GmbH, established in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's rehabilitation robots are specifically utilized for gait rehabilitation in neurological patients as well as in orthopedic patients recovering from joint replacements. With a team boasting over 12 years of combined experience in rehabilitation robotics and a strong network within the clinical community, ReActive Robotics is well-equipped to advance its innovative solutions in medical technology. The company emphasizes the importance of collaboration with advisors who support various aspects of product development, including patient access, engineering, legal compliance, and medical device registration.